S230. LONG-TERM ANTIPSYCHOTIC MEDICATION IN SCHIZOPHRENIA: BENEFITS, RISKS AND FOLLOW-UP: DATA FROM FINNISH COHORT STUDIES AND SYSTEMATIC REVIEW

BACKGROUND: Millions of people use antipsychotic medications. Thousands of clinicians (often non-psychiatrists) prescribe and monitor them every day. Existing research reports mostly favorable risk-benefit ratio during the first years of schizophrenia, but their risk-benefit ratio and maintenance ef...

Descripción completa

Detalles Bibliográficos
Autores principales: Isohanni, Matti, Miettunen, Jouko, Jääskeläinen, Erika, Moilanen, Jani, Hulkko, Anja, Huhtaniska, Sanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5888038/
http://dx.doi.org/10.1093/schbul/sby018.1017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5888038/
http://dx.doi.org/10.1093/schbul/sby018.1017

Ejemplares similares